The FDA recently approved a once monthly injectable slow-release
drug called Okeydorph to treat patients that are addicted to
opiates.
Explain a pharmacodynamic mechanism by which the same drug can
be excitatory in one area of the brain and inhibitory in another
part of the brain. Be as specific as possible for maximum
points
The FDA recently approved a once monthly injectable slow-release drug called Okeydorph to treat patients that are addict
-
answerhappygod
- Site Admin
- Posts: 899604
- Joined: Mon Aug 02, 2021 8:13 am
The FDA recently approved a once monthly injectable slow-release drug called Okeydorph to treat patients that are addict
Join a community of subject matter experts. Register for FREE to view solutions, replies, and use search function. Request answer by replying!